Opko Health to Acquire Inspiro Medical Ltd.

| Printer friendly version

According to the South Florida Business Journal and Opko press release, Miami Florida-based Opko Health, Inc. has entered into a definitive agreement to acquire Israeli medical device company Inspiro Medical Ltd.  The terms of the acquisition are undisclosed, but will likely be released in future SEC filings.

Inspiro Medical Ltd. describes itself as a medical device company dedicated to the development of a global inhalation platform designed to deliver both small molecules such as corticosteroids or beta agonists; and macromolecules such as antibodies or vaccines.

Inspiro Medical’s flagship product is a dry powder inhaler, the Inspiromatic.  According to Inspiro Medical’s website, the Inspiromatic offers three significant improvements over other inhalers: first, the Inspiromatic works with extremely low inhalation flow rates; second, real-time feedback interface guides the patient and assures proper inhalation technique (namely, a green or red flashing light to indicate proper inhalation and a beeper after the dose has been delivered); and third, an integrated data logger stores patient use data for easy access and transmission by electronic devices, such as smart phones (particularly useful for assessing patient compliance).

Opko Health, Inc. describes itself as a multi-national pharmaceutical and diagnostics company (having 96.5M in 2013 revenues, according to its Mar. 3, 2014 filed 10K) that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging its discovery, development, and commercialization expertise and its novel and proprietary technologies.

Nimrok Kaufmann, CEO and Co-Founder of Inspiro Medical Ltd. stated:

We are extremely proud of Inspiro’s success in bringing our smart Inspiromatic™ respiratory drug-delivery device to market. With Inspiro now a part of OPKO, we will be able to help more people faster. Inspiro joining OPKO is a big win for the shareholders of both Inspiro and OPKO, as well as good news for our patients and physicians.


Leave a Reply

By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.